Intranasal Anesthetic Spray Shows Potential to Reduce Surgical Anxiety and Pain
Published: 11 Mar 2026
Author: Precedence Research
Researchers in Mumbai have introduced a novel nasal anesthetic spray designed to help reduce anxiety and pain during surgical procedures. A group of medical professionals and researchers created the invention with the goal of enhancing patient comfort during surgeries while streamlining anesthesia delivery techniques. The spray contains drugs like lignocaine midazolam and ketamine which together give patients undergoing medical procedures sedation pain relief and calming effects.
Innovative Drug Delivery Approach Improves Surgical Comfort
The newly developed spray works by delivering anesthetic agents through the nasal passage, allowing the drugs to be absorbed rapidly into the bloodstream. When compared to some conventional administration methods like injections, this approach may offer a quicker onset of action. The spray helps stabilize patients and effectively manage discomfort prior to and during surgical procedures by facilitating rapid absorption.
The researchers claim that the treatment is especially helpful when rapid pain relief and anxiety control are needed because it combines sedative and anesthetic agents in a single formulation. Additionally, the spray may lessen the need for repeated injections, which are frequently linked to patient discomfort and stress. Consequently, this strategy may facilitate surgical procedures for patients and medical personnel alike.
Growing Focus on Patient-Centric Pain Management Solutions
Medical experts believe the new intranasal anesthetic spray could be especially beneficial in emergency care, minor surgical procedures, and situations involving patients who are highly anxious about surgery. Pediatric patients and individuals who fear needles may also benefit from this non-invasive administration method. By minimizing procedural discomfort, the innovation may help improve the overall surgical experience while maintaining effective anesthesia control.
Additionally, by guaranteeing early pain management and better patient cooperation during procedures, the nasal spray may help improve perioperative care according to researchers. The strategy is in line with the larger movement in healthcare toward patient-centered treatment plans that put comfort security and quicker recovery first.
According to Precedence Research, the global post-operative pain management market size accounted for USD 45.19 billion in 2025 and is expected to grow from USD 47.43 billion in 2026 to approximately USD 73.26 billion by 2035, expanding at a CAGR of 4.95% during the forecast period. Rising demand for advanced drug delivery systems, non-invasive anesthesia options, and improved pain management techniques is expected to drive market growth in the coming years.
The creation of novel remedies like intranasal anesthetic sprays is a reflection of the continuous efforts by medical professionals and researchers to improve surgical results while lowering patient discomfort. Such technologies might play a significant role in contemporary surgical pain management techniques as more clinical research and trials are conducted.